4月8日,据外媒报道,细胞分析公司Celcuity宣布与辉瑞公司达成全球许可协议,辉瑞将gedatolisib(一种1b期pan-PI3K / mTOR抑制剂)专有权授予给Celcuity。Gedatolisib正在临床开发中,用于治疗ER + / HER2-阴性的晚期或转移性乳腺癌患者。
根据许可协议条款,辉瑞向Celcuity提...查看全文
美股 美股开盘 | 三大指数涨跌不一,搜狐(SOHU.US)涨超13% 2021年4月9日 20:31:45 智通财经APP获悉,4月9日(周五)美股开盘,三大指数涨跌不一。截至发稿,道指涨0.18%,标普500指数跌0.03%,纳指跌0.41%。 个股消息 细胞分析公司Celcuit... 网页链接
格隆汇4月9日丨Celcuity(CELC.US)盘前大涨38.78%报19.86美元。公司周四表示,已与辉瑞公司签署了一项全球许可协议,获得了开发和商业化辉瑞Gedatolisib的全球许可。Gedatolisib正处于临床开发阶段,用于治疗某些类型的乳腺癌患者。Celcuity表示:“来自103... 网页链接
$Celcuity Inc.(CELC)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2018-11-07 AccNo: 0001437749-18-019819 Size: 13 KB 网页链接
$Celcuity Inc.(CELC)$ D/A [Amend] - Notice of Exempt Offering of Securities Filed: 2018-11-07 AccNo: 0001437749-18-019804 Size: 13 KB 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-10-19 AccNo: 0001144204-18-054599 Size: 16 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Celcuity Inc.(CELC)$ EFFECT - Notice of Effectiveness Filed: 2018-10-04 AccNo: 9999999995-18-002545 Size: 1 KB 网页链接
$Celcuity Inc.(CELC)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-09-21 AccNo: 0001144204-18-050320 Size: 561 KB 网页链接
$Celcuity Inc.(CELC)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-09-21 AccNo: 0001144204-18-050320 Size: 561 KB 网页链接
$Celcuity Inc.(CELC)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-09 AccNo: 0001144204-18-043344 Size: 4 MB 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001144204-18-043302 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-08-09 AccNo: 0001144204-18-043302 Size: 180 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Celcuity Inc.(CELC)$ 8-K - Current report Filed: 2018-05-16 AccNo: 0001144204-18-029073 Size: 184 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 5.07: Submissi...